NCT02966730 · Interventional trial
Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy
Overall registry status Terminated
Early Phase 1
Conditions Follicular Lymphoma, Follicular Lymphoma Grade IIIa, Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory